The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat ...
The most common side effects of GLP-1 medicines are related to digestion: nausea, vomiting, diarrhoea, indigestion, stomach ...
The Therapeutic Goods Administration issued a new warning for GLP-1 receptor agonists, including Ozempic and Mounjaro, on ...
Australia's medicines regulator issues a safety warning over the potential risk of suicidal thoughts and behaviours when ...
FDA and WHO identified semaglutide suicidal thought reports, exceeding those of other diabetes medications in their adverse ...
The WHO’s announcement came hours after Australia released a safety alert over the potential risk of suicidal thoughts and behaviours for people using the medicines.
The Australian medicines regulator has issued a mental health safety warning for a drug widely used for weight loss.
AAP Newsroom on MSN
Mental health warning issued for weight-loss drugs
The Australian medicines regulator has issued a mental health safety warning for a drug widely used for weight loss.
Alarming reports have surfaced after the national medicines watchdog disclosed information linking users of popular weight ...
Easier to take, just as effective and far cheaper than fat jab rivals such as Ozempic and Mounjaro, a promising new pill is ...
Australia's TGA has added mental health warnings to Ozempic and other GLP-1 drugs after reports of depression and suicidal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback